Shoulder Prosthesis Joins Class II Regulatory Tier
Published Date: 6/5/2026
Rule
Summary
The FDA is officially putting the shoulder joint humeral ceramic head/metallic stem prosthesis into Class II, meaning it now has special safety rules but fewer red tape hurdles. This change helps patients get safer, innovative shoulder implants faster and makes life easier for makers by lowering regulatory costs. The new classification is effective June 5, 2026, but has been in effect since December 16, 2022.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Hemi‑shoulder implant moved to Class II
If you need a shoulder humeral (hemi‑shoulder) implant, the FDA has classified the ceramic head/metallic stem prosthesis as Class II (special controls). The final order is effective June 5, 2026 and was applicable on December 16, 2022; FDA says this classification provides a reasonable assurance of safety and is intended to enhance patient access to innovative shoulder implants by reducing regulatory burdens.
Device now subject to 510(k) pathway
Manufacturers of this shoulder hemi prosthesis must submit a premarket notification under section 510(k); FDA has not exempted this device under section 510(m) of the FD&C Act. The device’s Class II status means sponsors can use the 510(k) process rather than premarket approval (PMA).
New special controls manufacturers must meet
Manufacturers must meet the special controls codified at 21 CFR 888.3695, including clinical data on shoulder function and adverse events; non‑clinical performance testing (mechanical fatigue, fretting/corrosion, static strength, modular disassembly strength, wear analysis, and worst‑case range of motion); biocompatibility for all patient‑contacting components; sterility and pyrogenicity performance data; validation of reprocessing instructions for reusable components; shelf‑life data demonstrating sterility and package integrity; and labeling with validated reprocessing methods and a shelf life.
De Novo classification creates a predicate
Because FDA classified this device via the De Novo process, the device can serve as a predicate for future devices of that type; other sponsors can rely on this predicate to use the 510(k) process rather than submitting a De Novo request or a PMA.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11303 — Intent To Exempt Certain Unclassified Medical Devices From Premarket Notification Requirements; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is planning to exempt some unclassified medical devices from the usual premarket notification rules, making it easier and faster for these devices to reach the market. This change affects manufacturers of certain medical devices and could save them time and money. The new guidance is effective starting June 5, 2026, but the FDA is still open to feedback from the public.
2026-11302 — Medical Devices; Orthopedic Devices; Classification of the Absorbable Metallic Bone Fixation Fastener
The FDA is officially classifying absorbable metallic bone fixation fasteners as Class II devices with special safety rules, making them easier to get to patients while keeping them safe and effective. This change helps doctors and patients by reducing red tape and encouraging new, helpful bone-fixing tech. The new rules took effect on June 5, 2026, but have been in place since March 29, 2023, so manufacturers should already be on board.
2026-11308 — Medical Devices; Orthopedic Devices; Classification of the Resorbable Calcium Salt Bone Void Filler Containing a Single Approved Aminoglycoside Antibacterial
The FDA is officially putting a special bone filler that slowly dissolves and fights bacteria into a safer, easier-to-manage category called Class II. This change helps make sure the product is safe and effective while speeding up patient access to this cool new tech. It’s been in effect since May 2022, so companies and patients can expect smoother approvals and fewer hoops to jump through.
2026-11060 — Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities-Questions and Answers; Revised Draft Guidance for Industry; Availability
The FDA just released a revised draft guide to help drug and device makers share important cost and coverage info with insurance companies and similar groups. This update clears up how to talk about approved products, unapproved products, and new uses, making it easier for everyone to understand the rules. Companies should send their feedback by August 3, 2026, so the FDA can finalize the guide—potentially speeding up coverage decisions and saving money.
2026-11062 — Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications
The FDA is officially pulling the plug on 16 generic drug approvals because the companies told them these medicines aren’t being sold anymore. This change kicks in on July 6, 2026, and it won’t stop companies from trying again later if they want. If you’re a drug maker or just curious, this means fewer old approvals cluttering the books and a cleaner, fresher drug list.
2026-11101 — Third Annual Animal Drug User Fee Educational Conference; Public Meeting
The FDA is hosting its Third Annual Animal Drug User Fee Educational Conference on July 7, 2026, to help drug makers and animal health experts understand the new animal drug approval process. This free event is both in-person and online, making it easy to join. Stakeholders should register early and can send feedback within 90 days after the meeting to help shape future policies and fees.
Previous / Next Documents
Previous: 2026-11304 — Establishment of Class E Airspace; Wickenburg, AZ
Starting September 3, 2026, new Class E airspace will be set up around Wickenburg, Arizona to help pilots fly safely using instruments, especially when the weather isn’t great. This change mainly affects pilots and air traffic controllers by improving flight rules and procedures in the area. No extra costs for the public, just smoother and safer skies!
Next: 2026-11307 — Amendment of Class E Airspace; Springfield, KY
The FAA is updating the Class E airspace around Lebanon Springfield Airport in Springfield, KY, to match new flight procedures and correct the airport’s name and location info. This change helps pilots fly safely using instruments and kicks in on September 3, 2026. No extra costs for anyone—just smoother skies and clearer rules!